EKF Diagnostics (LON:EKF) Stock Price Crosses Above 200 Day Moving Average - Time to Sell?

Key Points

• EKF Diagnostics briefly crossed above its 200‑day moving average (200‑day MA GBX 25.73) during Thursday trading — the stock traded as high as GBX 25.90 but last traded at GBX 24.60 on volume of 72,517 shares.
• Company fundamentals show a small market cap (£106.05m) and a high valuation (P/E 52.34) with modest profitability (net margin 4.12%, ROE 3.01%) and notable leverage (debt/equity 2.01).
• EKF is an AIM‑listed diagnostics group focused on point‑of‑care hematology and diabetes analyzers and life‑sciences enzyme manufacturing, selling into over 120 countries from sites in the UK, US and Germany.

EKF Diagnostics Holdings plc (LON:EKF - Get Free Report) passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 25.73 and traded as high as GBX 25.90. EKF Diagnostics shares last traded at GBX 24.60, with a volume of 72,517 shares changing hands.

EKF Diagnostics Price Performance

The company's 50 day moving average price is GBX 24.93 and its 200-day moving average price is GBX 25.73. The company has a market cap of £106.05 million, a price-to-earnings ratio of 52.34 and a beta of 0.49. The company has a debt-to-equity ratio of 2.01, a quick ratio of 1.77 and a current ratio of 4.16.

EKF Diagnostics (LON:EKF - Get Free Report) last released its earnings results on Tuesday, March 24th. The company reported GBX 0.47 EPS for the quarter. EKF Diagnostics had a net margin of 4.12% and a return on equity of 3.01%. On average, equities research analysts forecast that EKF Diagnostics Holdings plc will post 2.2987842 earnings per share for the current fiscal year.

EKF Diagnostics Company Profile

EKF is an AIM-listed global diagnostics business focussed on: ● Point-of-Care analysers in the key areas of Hematology and Diabetes ● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications. EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.